Xencor reported $45.96M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
Alnylam Pharmaceuticals ALNY:US $ 554.65M 59.82M
Amgen AMGN:US $ 14585M 1716M
Arrowhead Research ARWR:US $ 195.43M 28.25M
AstraZeneca AZN:LN 22222M 709M
Biogen BIIB:US $ 4211.6M 864.4M
Bristol Myers Squibb BMY:US $ 18991M 1661M
Cytokinetics CYTK:US $ 61.77M 25.84M
Epizyme EPZM:US $ 40.89M 1.89M
GlaxoSmithKline GSK:LN 21387M 1112M
Karyopharm Therapeutics KPTI:US $ 58.12M 3.88M
Macrogenics MGNX:US $ 69.92M 16.88M
Novartis NOVN:VX SF 29633M 527M
Regeneron Pharmaceuticals REGN:US $ 3732.4M 514.6M
Seattle Genetics SGEN:US $ 433.83M 44.22M
Xencor XNCR:US $ 45.96M 53.97M